To characterize the role of MYC in SCLC, the Rb/TP53/Myc-overexpression (RPM) mouse model was developed, which represents MYC-overexpressing NE-low SCLC with NEUROD1 expression [42]. The gene discussed is TP53; the disease is small cell lung carcinoma.